The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death. Sorafenib is approved by the U.S. Food and Drug Administration to be a first-line chemotherapy agent for patients with advanced HCC. A portion of advanced HCC patients can benefit from the treatment with sorafeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xinyao, Zhu, Hua, Shen, Yang, Zhang, Xiaoyu, He, Xiaoqin, Xu, Ximing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340683/
https://www.ncbi.nlm.nih.gov/pubmed/34367979
http://dx.doi.org/10.3389/fonc.2021.696705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340683/
https://www.ncbi.nlm.nih.gov/pubmed/34367979
http://dx.doi.org/10.3389/fonc.2021.696705

Ejemplares similares